baber/WOPTO huggingface dataset:
Patent AU-2005244261-B2 (AU)
Title: Multiple-variable dose regimen for treating TNFalpha-related disorders
Inventor: ELLIOT CHARTASH
IPC: C07K16/24
Filed: 2005-04-11
Granted: 2011-09-22
Abstract: Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
Patent AU-2005268493-B2 (AU)
Title: Point-to-point repair response mechanism for point-to-multipoint transmission systems
Inventor: LEON DAVID
IPC: H04H20/00
Filed: 2005-07-27
Granted: 2009-10-08
Abstract: This invention relates to a method, a system, a transmitter, a network element, a receiver and software applications in a system for transmitting data symbols, wherein one or more data symbols are transmitted from a transmitter to one or more receivers within a point-to-multipoint transmission session, wherein said data symbols are furnished with first-type headers obeying a file delivery protocol, wherein one or more repair data symbols are transmitted from a repair server to one specific receiver of said receivers within a point-to-point repair session, and wherein said repair data symbols are furnished with one or more second-type headers at least partially obeying said same file delivery protocol.
Patent AU-2005268595-B2 (AU)
Title: Line marking apparatus
Inventor: RIDGLEY SWATTON STEWART NATHAN
IPC: A63C19/08
Filed: 2005-08-05
Granted: 2011-06-23
Abstract: A line marking apparatus includes a chassis (2) provided with wheels (4) and with means (6) for propelling the apparatus. A line marking head (12) is adapted to dispense line marking material so as to mark a line upon a surface over which the apparatus is moved. A support (14) is provided for the line marking head such that the line marking head is movable laterally relative to the chassis. Lateral movement of the line marking head is controlled by a controller which includes a detector (32) for detecting a beam of electromagnetic radiation indicative of the line to be marked and which also includes control means for moving the line marking head in response to detection of the beam by the detector, whereby lateral movement of the line marking head relative to the chassis is controlled such that the line marking head substantially follows the line to be marked irrespective of whether the chassis deviates from the direction of such line.
Patent AU-2005287603-B2 (AU)
Title: Floor panel and floor covering composed of such floor panels
Inventor: CAPPELLE MARK
IPC: A47G27/02
Filed: 2005-09-14
Granted: 2011-03-10
Abstract: Floor panel consisting at least of a board-shaped element (3), whereby this floor panel (1), at least at two opposite edges (4-5), is provided with coupling parts (6-7) allowing that several of such floor panels (1) can be coupled to each other, whereby the coupling parts have contact portions forcing the floor panels (1), in the coupled condition, with a tension force (T1) at least laterally towards each other, characterized in that said coupling parts (6-7) also comprise support portions (17-18), which, in the coupled condition (8) of the respective floor panels (1), create a fixation in the mutual position of the contact portions (12-13) cooperating under tension.
Patent AU-2005330566-B2 (AU)
Title: Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
Inventor: DREYFUS DAVID H
IPC: A61K38/00
Filed: 2005-04-29
Granted: 2008-09-18
Abstract: External Guide Sequence (EGS) are described that target proteins required for generation and modification of the immunoglobulin and T-cell repertoire that are useful for treatment or prevention of inflammatory or related diseases. Formulations suitable for administration of an EGS for treatment of inflammatory or related disease are described. The formulations may be administered via inhalation, injection, or orally. The formulations may be in the form of an ointment, lotion, cream, gel, drop, suppository, spray, liquid, powder, granule, solution, suspension, capsule, or tablet. Methods of treating inflammatory or related diseases by administering an effective amount of an EGS in a pharmaceutically acceptable carrier are also described. In preferred embodiments, the disease is asthma, allergic rhinitis, food allergies, atopic skin disease such as eczema, IL-4 and/or IL-13 dependent malignancies, IL-4 and/or IL-13 dependent autoimmune diseases, atopic diseases, the flu, and diseases caused by IL-4 dependent replication of viruses.
Patent AU-2006204017-B2 (AU)
Title: Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
Inventor: QI SHUAI
IPC: A61P3/10
Filed: 2006-01-05
Granted: 2011-10-06
Abstract: The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome and other diseases and conditions that are mediated by excessive glucocorticoid action.
Patent AU-2006235759-B2 (AU)
Title: 1,4-substituted piperazine derivative
Inventor: KAWAMOTO HIROSHI
IPC: C07D417/04
Filed: 2006-04-05
Granted: 2011-07-28
Abstract: A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: (I) wherein R represents a branched alkyl group having 3 to 9 carbon atoms or the like; R represents a 6-membered heteroaryl group having 1 or 2 nitrogen atoms or the like; R represents a hydrogen atom, an alkanoylamino group or the like; R represents a hydrogen atom, a lower alkyl group or the like; X represents an oxygen or sulfur atom; X represents an oxygen atom or a single bond; and m is an integer of 0 to 4. This compound has a metabotropic glutamate receptor 1 inhibitory effect, and therefore is useful for the treatment of a brain disorder such as convulsion, acute pain, inflammatory pain, chronic pain, cerebral infraction or transient cerebral ischemic attack, a mental dysfunction such as schizophrenia, and a disease such as anxiety and drug addiction.
Patent AU-2006235821-B2 (AU)
Title: Cupboard lock
Inventor: SIMS WILLIAM
IPC: E05B65/44
Filed: 2006-10-31
Granted: 2012-05-17
Abstract: 15452 Amended Complete Specification clean 30 3 12 Abstract The invention provides a lock assembly (10) adapted to operate a bolt sub assembly (26) or a latch sub assembly (27). The lock assembly (10) has a first housing (11) adapted to accommodate a lock means (14) operable by a key, and a 5 second housing (12) adapted to mate with the first housing (11) to accommodate interchangeably either the bolt sub assembly (26) or the latch sub assembly (27), in operable relationship with the lock means (14). The second housing (12) is adapted for mating with the first housing (11) in any one of four orientations. Each orientation differs from the other orientations by 10 rotation through 90', co co cv coN to 0
Patent AU-2006299152-B2 (AU)
Title: Method and assembly for dispensing a product from a form-retaining container
Inventor: JOSEPH MAAS WILHELMUS JOHANNES
IPC: B67D7/02
Filed: 2006-09-25
Granted: 2011-08-18
Abstract: The invention relates to a method for dispensing one or more products (8) to an assembly (1) for carrying out this method, comprising a form-retaining container (2) for receiving the product(s) (8), said container (2) having an outflow opening (6), and means (9) for introducing into the container (2) a medium (15) for displacing the product(s) (8). The displacing medium introduction means (9) are arranged for introducing the displacing medium (15) into the container (2) such that it exerts on the product(s) (8) substantially only a force directed towards the outflow opening (6). The displacing medium introduction means (9) may include a chamber (18) that is separated from the part (19) of the container (2) containing the product(s) (8) by means of a flexible diaphragm (17). The dispensing assembly (1) may further include a dispensing adapter (30) connected to the container (2) around the outflow opening (6) and supporting a movable closure member (32).
Patent AU-2006336103-B2 (AU)
Title: A bearing, a wind turbine and methods of manufacturing a bearing
Inventor: OLSEN NIELS CHRISTIAN
IPC: F16C33/58
Filed: 2006-01-23
Granted: 2010-08-19
Abstract: The invention relates to a bearing for a wind turbine comprising bearing rings with raceways, and at least one row of bearing balls or rollers positioned between said raceways. At least one of said raceways comprises one or more indentation areas in relation to a standard shape of the raceways. The invention also relates to a wind turbine and methods for manufacturing a bearing.
Patent AU-2007209072-B2 (AU)
Title: Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
Inventor: COMMERCON ALAIN
IPC: C07D487/04
Filed: 2007-01-22
Granted: 2012-09-27
Abstract: The present invention is related to new tomaymycin of formula (I) derivatives, their process of preparation and their therapeutic uses .
Patent AU-2007273525-B2 (AU)
Title: Supercooling promoting agent
Inventor: FUJIKAWA SEIZO
IPC: C09K5/08
Filed: 2007-07-11
Granted: 2010-09-16
Abstract: During the investigation of the mechanism that cellular water in woody plants growing in cold districts keeps liquid state at low temperature, the inventors have studied to identify the causative substances. As the results, the present inventors identified supercooling promoting agents in woody plants.  The supercooling ability of identified flavonoid glycoside and synthesized flavonoid glycoside with similar structure was tested. It was found that the supercooling promoting agent comprising these flavonoid glycosides enables to stably supercool bulk water at low temperature for long-term. The aqueous solution containing the supercooling promoting agent of the present invention is useful to store biological materials at low temperature.
Patent AU-2007278368-B2 (AU)
Title: Regulatory nucleic acid elements
Inventor: ENENKEL BARBARA
IPC: C12N15/67
Filed: 2007-06-15
Granted: 2013-12-19
Abstract: The invention relates to DNS-sequences, particularly transcription- or expression increasing elements (TE-elements) and the use thereof on an expression vector in connection with an enhancer, a promoter, a product gene and a selection marker. The invention describes the sequence No. 1 and the TE-elements TE-01, -02, -03, -04, - 06, -07, -08, -10, -11 or -12. Due to their small size TE-06, TE-07 or TE-08 are particularly preferred. The sequence No. 1 is from a sequence region being upstream of the code region of the Ub/S27a-genes of CHO-cells. TE-elements cause an expression increase of the product gene with stable integration into the eukaryotic genome, preferably the CHO-DG44-genome. Chromosomal position effects are thus overcome, shielded or eliminated. Thus, the content of high producers of a transfection deposit and also the absolute expression level is increased up to fifteen fold.
Patent AU-2007295179-B2 (AU)
Title: Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
Inventor: BENDER JOHANNES CASPAR MATHIAS ELIZABETH
IPC: A61K9/00
Filed: 2007-09-14
Granted: 2013-05-30
Abstract: One aspect of the invention relates to a pharmaceutical dosage unit for sublingual, buccal, pulmonary or oral administration, said dosage unit having a weight of 20-500 mg and comprising 1-80 wt.% of a microgranulate that is distributed throughout a solid hydrophilic matrix; said microgranulate being characterised in that it: has a volume weighted average diameter of 5-100 m; contains at least 0.01 wt.%, preferably at least 0.1 wt.% of one or more water-insoluble pharmaceutically active substances; contains at least 10 wt.%, preferably at least 20 wt.% of an emulsifier component; and is capable of forming a micro-emulsion upon contact with saliva or water. The dosage units of the present invention achieve the inherent benefits of oral delivery whilst at the same time realising a high transmucosal absorption rate of the cannabinoids contained therein. Other aspects of the present invention relate to the use of the aforementioned dosage units in the therapeutic or prophylactic treatment and to a process for the manufacture of said dosage units.
Patent AU-2007311168-B2 (AU)
Title: Ventilator for rapid response to respiratory disease conditions
Inventor: ONG NICHOLAS
IPC: A61M16/00
Filed: 2007-10-12
Granted: 2012-11-22
Abstract: The present invention relates generally to the field of ventilators, and, more specifically, to a ventilator system that addresses respiratory distress due to the onset of an epidemic or pandemic disease state. In particular, the present invention is a ventilator system that can be manufactured quickly with minimal skill requirements and employed rapidly in response to epidemic respiratory disease conditions.
Patent AU-2007321357-B2 (AU)
Title: Application of block copolymers based on vinyl lactams and vinyl acetate as solubilizers
Inventor: KOLTZENBURG SEBASTIAN
IPC: C09K23/00
Filed: 2007-10-31
Granted: 2012-06-14
Abstract: The invention relates to the application of polyvinyl lactam-polyvinyl acetate block copolymers as solubilizers for agents which are minimally soluble in water.
Patent AU-2007351658-B2 (AU)
Title: Oil producing microbes and methods of modification thereof
Inventor: RADIANINGTYAS HELIA
IPC: A23L23/10
Filed: 2007-07-30
Granted: 2013-05-30
Abstract: Disclosed are compositions and methods related to oil producing microbes that can produce unsaturated fatty acids which can be purified and used. Also disclosed are methods to modify said fatty acid concentrations within total lipid compositions using fatty acid production antagonists which either inhibit or stimulate certain components of the classical fatty acid production pathway thought to exist within oil producing microbes.
Patent AU-2008233343-B2 (AU)
Title: Food product simulating pieces of natural meat and method for producing same
Inventor: OGNEVA ELENA VLADIMIROVNA
IPC: A23L13/60
Filed: 2008-03-18
Granted: 2013-09-12
Abstract: The invention generally relates to the meat industry, specifically it relates to meat products which are firstly intended for pets, in particular for cats and dogs, or other domestic animals whose feeding diet includes natural meat and, more specifically the invention relates to a food product simulating natural meat chunks or pieces and a method for producing same. The disclosure of the invention provides for a food product having pieces simulating a piece of natural meat, wherein one of the surfaces of each piece has a distinctly defined structure similar to the striated muscle fibre structure of natural meat. The disclosure of the invention provides also a method for producing such food product.
Patent AU-2008234115-B2 (AU)
Title: Method for producing sulphuric acid and installation for carrying out said method
Inventor: THIELERT HOLGER
IPC: C01B17/76
Filed: 2008-03-20
Granted: 2012-10-04
Abstract: The invention relates to a method for producing sulphuric acid. According to the invention, a crude gas containing SO is produced in a sulphuric acid recovery installation, the crude gas is conducted through at least one reaction container, in which a catalytic reaction of SO into SO takes place and the SO formed in this process is converted into sulphuric acid. The SOemission of at least one sub-stream of the gaseous stream that exits the sulphuric acid recovery installation is hydrogenated in an aftertreatment step with a gas rich in H. The gaseous stream containing HS that is thus formed is fed to the HS scrubber of a coke-oven gas installation or petrochemical installation. The invention also relates to an installation for carrying out said method.
Patent AU-2008236605-B2 (AU)
Title: Camouflaged composite military vehicle lamp
Inventor: DRAKE MATTHEW E
IPC: F21L14/04
Filed: 2008-02-01
Granted: 2012-07-26
Abstract: A composite lamp assembly for use on a camouflaged military vehicle comprises a lamp housing colored to match the camouflaged scheme of the vehicle. The lamp housing defines an interior space, a first opening and a plurality of second openings in communication with the interior space. The lamp assembly includes a clear lens attached to the housing to occupy the first opening and a plurality of diffusers attached to the housing to occupy the plurality of second openings, the diffusers being colored to match the camouflaged scheme of the vehicle. The lamp assembly further includes a circuit board arranged within the interior space of the lamp housing having first and second pluralities of LEDs mounted thereto. The first plurality of LEDs is positioned to provide light through the clear lens and the second is positioned to provide light through the diffusers.
Patent AU-2008243126-B2 (AU)
Title: Method and system to convert direct current (DC) to alternating current (AC) using a photovoltaic inverter
Inventor: LEONARD JOHN ANDREW
IPC: H02M3/00
Filed: 2008-11-05
Granted: 2012-05-10
Abstract: METHOD AND SYSTEM TO CONVERT DIRECT CURRENT (DC) TO ALTERNATING CURRENT (AC) USING A PHOTOVOLTAIC INVERTER A method to increase photovoltaic (PV) inverter (10) efficiency by disabling a DC-DC Boost includes: applying a DC power generated by a PV array (12) to the PV inverter; boosting (26, 118) the DC power from the PV array from a predetermined voltage level to a predetermine DC link voltage, wherein the PV array is regulated by the boosting to output a voltage at the predetermined voltage level; converting (122) the boosted DC power to AC power, and disabling (150) the boost of the power generated by the PV array after the array has a predetermined voltage level at least as great as the DC link voltage. I- LU (fl Lo L c) (DlL t0 c-'J X4.' cn0 a. c"J0.
Patent AU-2008259858-B2 (AU)
Title: Deposition of metal ions onto surfaces of conductive substrates
Inventor: DEFALCO FRANK G
IPC: C23C22/08
Filed: 2008-06-03
Granted: 2013-01-24
Abstract: The present invention provides compositions and processes for preparing metallic ions for deposition on and/or into conductive substrates, such as metals, to substantially eliminate friction from metal to metal contact. It is used in the aqueous embodiment to form new metal surfaces on all metal substrates. The processes form stable aqueous solutions of metal and metalloid ions that can be adsorbed or absorbed on and/or into conductive substrates. The aqueous solutions consist of ammonium alkali metal phosphate salts, and/or ammonium alkali metal sulfate salts mixed with a water soluble metal or metalloid salt from Group I through Group VIII of the periodic table of elements. The aqueous solutions allow for a nano deposition of the metal ions on and/or into the surfaces of conductive substrates. The surfaces created by the deposited metal ions will provide metal passivation and substantially eliminate friction in metal-to-metal contact without the use of hydrocarbon based lubricants.
Patent AU-2008275089-B2 (AU)
Title: Paper making compositions and processes using protein particulate, colloidal pigment, and latex polymer combinations
Inventor: DYKSTRA GERALD M
IPC: D21H19/36
Filed: 2008-07-10
Granted: 2012-01-19
Abstract: A composition for treating paper products comprising protein particulate, colloidal pigment, synthetic latex polymer, and preservative is described, as well as methods and an apparatus using the composition for such treatments, and products obtained thereby. The treated paper products preferably have improved strength, water holdout, and/or ink holdout, amongst other advantages and benefits.
Patent AU-2008294513-B2 (AU)
Title: Conversion method
Inventor: FANSELOW MARKUS
IPC: C12P7/10
Filed: 2008-09-03
Granted: 2013-05-30
Abstract: A process is described for the preparation of water-soluble cellulose hydrolysis products, which comprises admixing cellulose with an ionic liquid capable of solvating or dissolving at least some of the cellulose, said ionic liquid being a compound comprised solely of cations and anions and which exists in a liquid state at a temperature at or below 15O °C, the cations in said ionic liquid having the general formula (I), in which Z represents a nitrogen or phosphorus atom, R
Patent AU-2008348208-B2 (AU)
Title: Differentiated linear equalization at communication base stations
Inventor: BOTTOMLEY GREGORY E
IPC: H04B1/707
Filed: 2008-12-17
Granted: 2013-07-25
Abstract: The teachings presented herein improve the processing of individual signals of interest included in a received composite signal by computing combining weights and/or signal quality estimates for each signal of interest, e.g., for linear equalization, based on either shared or non- shared correlation estimates. As a non-limiting advantage, the use of shared correlation estimates reduces computational loading as compared to the processing load that would be needed for computing non-shared correlation estimates for all signals of interest. As a further non-limiting advantage, the conditional use of shared and non-shared correlation estimates provides for the use of non-shared correlation estimates where signal characteristic(s) of one or more of the signals of interest warrant such usage, e.g., for one or more high-rate signals of interest.
Patent AU-2008353507-B2 (AU)
Title: Identification of a manipulated or defect base station during handover
Inventor: NORRMAN KARL
IPC: H04W12/10
Filed: 2008-08-25
Granted: 2014-03-20
Abstract: A method of and arrangement for detecting a manipulated or defect base station of a communication network is disclosed, wherein a target base station, having selected one or more algorithms on the basis of a prioritized algorithm list (PAL) and a UE security capabilities (SCAP), reports UE SCAP related information to a core network node. The core network node having knowledge of the UE SCAP compares this information or parts of this information with the retrieved UE SCAP related information in order to be able to identify a manipulated or defect base station when acomparison fails to match.
Patent AU-2009216883-B2 (AU)
Title: Cationic copolymers formulated with pigmented cosmetic compositions exhibiting radiance with soft focus
Inventor: POLONKA JACK
IPC: A61K8/11
Filed: 2009-01-29
Granted: 2012-02-09
Abstract: A cosmetic composition is provided which includes a silicone elastomer, a cationic copolymer with monomeric units selected from at least an acryloylethyl tri(C-C alkyl)ammonium salt and light reflecting platelet shaped particles. The compositions are particularly useful to impart radiance as well as soft focus effects onto the skin. A particularly useful cationic copolymer is acrylamide/acryloylethyl trimethylammonium chloride/tris(hydroxymethyl) acrylamidomethane copolymer.
Patent AU-2009217444-B2 (AU)
Title: Ruthenium complex and photoelectric component using the same
Inventor: CHEN CHING-LIN
IPC: C09B57/10
Filed: 2009-09-22
Granted: 2013-02-14
Abstract: RUTHENIUM COMPLEX AND PHOTOELECTRIC COMPONENT USING THE The present invention relates to a ruthenium complex and a photoelectric component 5 using the same, and the ruthenium complex is represented by the following formula (I): RuL 2(NCS)2Am (I) wherein L, A and m are defined the same as the specification. The ruthenium complex of the present invention is suitable for Dye-Sensitized Solar Cell (DSSC). io Hence, the photoelectric characteristics of the DSSC manufactured with the ruthenium complex of the present invention can be improved.
Patent AU-2009222618-B2 (AU)
Title: NGNA compositions and methods of use
Inventor: JOHNSON KEN
IPC: A23L33/00
Filed: 2009-10-07
Granted: 2012-12-13
Abstract: NGNA COMPOSITIONS AND METHODS OF USE Abstract 5 The present invention relates to the field of viral disorders, and in particular to viral obesity. Compositions comprising nutraceutical agents are provided for treating viral obesity. Additionally, compositions comprising nutraceutical agents targeting adenoviruses are provided.